Publications by authors named "Matthias Hackenthal"

Claim this Profile
A
A phase II study of weekly docetaxel-cisplatin as first-line treatment for advanced non-small cell lung cancer.
Daniel Binder, Matthias Hackenthal, Lutz Graseck, Hans Schweisfurth, Christoph Schäper

J Thorac Oncol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis